한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
this year, china's capital market seems to be undergoing an epic transformation. from the h-share swap with haitong securities to the absorption and merger, and then to the implementation of the new "nine national policies", the entire industry landscape is quietly being reshaped. this restructuring will become a landmark case in china's capital market, and its scale and influence will touch the core of the entire industry.
2. sushiro’s reputation dispute: the truth behind the revelations made by the self-proclaimed employee
at the same time, a battle for the reputation of "sushiro" is also unfolding. from posts claiming to be from former employees to the clarification statement of guangzhou sushiro catering co., ltd., the incident has developed rapidly, triggering public concern about food safety and corporate reputation. however, what is the truth behind the incident?
3. braised food giants struggle: the frustration of closing stores and falling revenue
this year's marinated food market is full of challenges. the three major listed companies of leisure marinated food have closed stores, which highlights the fierce competition in the industry. although the price of raw materials has fallen, the number of stores has decreased, resulting in a decline in revenue, which has also put the marinated food giants in trouble.
4. the dream of “mass sales” and “explosive products”: ff’s second brand starts a new journey
between the capital market and technological innovation, another wonderful story is unfolding - ff's second brand strategy. jia yueting's "people's ai car people's choice co-creation" questionnaire survey activity involves global technical talents to jointly create a popular mass-produced model that meets the needs of the us market.
5. the future of long-acting growth hormone: intensified competition in the chinese market
novo nordisk's long-acting growth hormone parsifol injection has been accepted for marketing, opening a new chapter in the long-acting drug market. as more and more pharmaceutical companies enter the market, china's growth hormone market will usher in a new competitive landscape.
